Aarff.com does a followup on Duffy, a 10 year old Lab who underwent stem cell therapy two months ago in June 2011

Read this article:
Duffy Update, Post Stem Cell Therapy - Video

Kristen Lueck describes her improvements after receiving stem cell therapy at the Stem Cell Institute in Panama City, Panama

Excerpt from:
Stem Cell Therapy: Psoriatic Arthritis Treatment - Video

This is day 0 of the half match stem cell bone marrow transplant. during this day I received 13 bags of stem cells. This was the first major event after going through the initial steps to get my body ready to receive donated cells from my brother

Read this article:
Sickle Cell Stem Cell Bone Marrow Transplant 3 - Video

This video is 2 of 2 videos on the day I was to receive radiation during the preparation to receive donor stem cells from my brother. This video is created to help people see some of the steps they may need to do in order to receive a bone marrow transplant.

Read the original post:
Radiation - Sickle Cell Half Match Stem Cell Bone Marrow Transplant 2 - Video

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

The $3 billion California stem cell agency likes to align itself with the very best science. And as of today it is also hooked up with the best lobbyist in California – at least based on earnings.

CIRM hires many firms to perform work, given its unusual needs, rather than building a large and relatively permanent staff. The tasks of the outside contractors range from publishing the annual report to grant review matters. Today Laurel Rosenhall of The Sacramento Bee reported that one of the firms that CIRM has hired now ranks as the No. 1 lobbyist in California, based on its earnings.

The firm of Nielsen, Merksamer, Parrinello, Gross & Leoni pulled down nearly $5 million during the first three quarters of this year. The firm knocked KP Public Affairs out of the top spot, which it had held for at least the last 10 years.

Nielsen has had a contract with CIRM since its earliest days in 2005, but it doesn't amount to much in the scope of Nielsen's business. According to the latest CIRM report on outside contracting, Nielsen was paid $79,984 during the fiscal year 2010-2011 for services that also extended into the current fiscal year. The report did not list payments for earlier years, but it is our recollection that Nielsen was paid about $50,000 every year since 2005. It is not known whether the firm continues to hold a contract for the current fiscal year.

One of Nielsen's partners, Gene Erbin, was one of the drafters of Prop. 71, the ballot initiative that created the California stem cell agency in 2004. Merck and Pfizer, in addition to CIRM, are among the firm's clients.

Source:
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss

The prestigious Institute of Medicine earlier this month kicked off its $700,000 study of the California stem cell agency minus an important perspective – the view directly from California.

None of the persons on the 13-member panel evaluating the performance of the $3 billion enterprise comes from California. The reasons for that are not clear. The IOM is all but mum on the matter.

One could argue that it is not necessary to be geographically located in California to determine whether CIRM is working at peak performance. However, some conditions do exist in California that are difficult for many others to grasp. They include its state budget crisis that has now placed the once Golden State at the bottom of the heap in terms of its credit. Some even liken it to Greece. Obviously that situation can be understood in the abstract by reading The Sacramento Bee and the Los Angeles Times. But the intensity and emotion surrounding that issue and others are difficult to comprehend for many folks living in more blessed states.

Count among the other volatile issues the cutbacks in the state's once vaunted higher education system, including the University of California, which showed its back to students by increasing tuition by nearly 18 percent this fall. Couple that with a visceral antipathy -- and that is putting it mildly -- among some Californians to what they regard as execessive state salaries, including those at the stem cell agency.

What does all this have to with financing stem cell research through an agency that was supposed to have a guaranteed stream of income isolated from mischief that could be wreaked by the governor or legislature. It turns out that CIRM's cash flow is not as guaranteed as its backers believed. Instead of issuing bonds, the state is going to finance the agency over the next 18 months with commercial paper, if necessary. That's because Gov. Jerry Brown wants to reduce the interest costs on state borrowing, which have risen sharply and now consume 8 percent of the state budget along with funds that could otherwise go to educate California's children, among other things.

Brown's parsimony is famous. During his first term in office, he denied pay raises to state college professors, saying they are amply rewarded through "psychic income." More recently, he objected to out-of-state travel by CIRM staff. Too much "lollygagging in London on the taxpayer's dime," a Brown spokesman said. CIRM Chairman Jonathan Thomas promptly cut travel in the chairman's office by 50 percent and asked CIRM President Alan Trounson to do the same for the rest of the staff.

It is an environment that can be difficult to navigate under the best of circumstances. It places limitations on the stem cell agency and tends to focus its operations and funding in different directions than might be the case if California's economic climate were rosier.

The IOM has no real response to the question of why no Californian is on the panel. The California Stem Cell Report last week asked the institute whether an overt decision had been made to exclude persons from California. The IOM did not answer directly. Instead it referred to a generic description of how panel members are selected. The institute's unwillingness to address the specific question does not speak well for the openness and transparency of the IOM examination of CIRM.

Currently the IOM does have a comment period available on the selection of the panel members, who will not become official for another three days. Interested parties can make their views known to the IOM by using this link.

A Californian or two on the IOM panel would help to bring a valuable, broader perspective to this important study, which is sure to affect the future of the state's stem cell research and voter approval of another possible multibillion dollar bond issue in the next few years.

Source:
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss

Dr Tristan McKay of the William Harvey Research Institute at Queen Mary University of London presents the current status of stem cell therapies for human disease. He highlights the opportunities and controversies in the field, and sets out the challenges ahead. Hosted on Barts Cancer Institute Channel on behalf of Gene Therapy, Nature Specialist Journal Web links.

Excerpt from:
BSGT-ESGCT What is Stem Cell Therapy? - Video

Dr Lyras Injection Pen Plasic Surgery of the face, injectables, Threads, Stem Cells, Rejuvenation, Brazil, Ivo Pitanguy, Ioannis Lyras, Best Techniques to look good and feel good

Read more here:
Dr Lyras Plastic Surgery - Skin Needling 3 - Tv 2011 - Video

See the rest here:
Stem Cell Therapy Cure Hair Loss. More at http://www.stemcellfusion.com - Video

Dr. Neil Riordan presents data on human umbilical cord-derived stem cell treatments. Dr.

View post:
Adult Stem Cell Therapy: Side Effects of Umbilical Cord Derived Stem Cells - Video

After suffering from rheumatoid arthritis for five years, Michael Foster underwent stem cell therapy at the Stem Cell Institute in Panama City, Panama. Now, he is reports that he is basically pain free.

Read the original here:
Stem Cell Treatment for Rheumatoid Arthritis - "I got my life back" - Video

Carolyn C.

Read more from the original source:
Stem Cell Treatment for Cerebral Palsy (Periventricular Leukomalacia) - Video

World Stem Cells, LLC - BillH Stem Cell Therapy

Go here to see the original:
World Stem Cells, LLC - BillH Stem Cell Therapy Video - Video

T-6 spinal cord injury patient, Trish Stressman, speaks about her recovery from spinal cord injury after receiving a combination of stem cells harvested from her bone marrow and from human umbilical cord blood and matrix.

Visit link:
Stem Cells - Treatment for Spinal Cord Injury - Video

Tamara, a mother of two, survived a car crash in Elko, Nevada. She suffered significant spinal injuries during the accident and underwent a lot of surgery following it to secure her spine. In Shijiazhuang, China she received a regimen of adult stem cells and physical therapy to enhance her recovery efforts.

See the original post here:
Tamara Marquis - SCI Stem Cell Patient - Video

The Second Conference on Stem cells and Regenerative Medicine. Arranged by the Stem Cell Unit, Anatomy Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Link:
The Second Conference on Stem cells and Regenerative Medicine_2011.wmv - Video

Treatment of Depression More Than Triples in the US Over the Last 10 Years

Among people receiving treatment for depression in the US, the percentage of those on antidepressant medication has risen dramatically, while fewer are opting for time on the couch in psychotherapy.

The number of Americans treated for depression soared from 1.7 million to 6.3 million between 1987 and 1997, and the proportion of those receiving antidepressants doubled.

The researchers attributed the sharp increases to the emergence of aggressively marketed new drugs like Prozac, the rise in managed care and an easing of the stigma attached to the disease.

The study found that the share of patients who used antidepressant medication climbed from 37% to nearly 75%. At the same time, the proportion who received psychotherapy declined from 71% to 60%.

The publicizing of newer antidepressants that have fewer side effects - such as Prozac, which was introduced in late 1987 - has helped make patients more willing to seek treatment, the researchers said. This publicity has included pharmaceutical industry efforts to market the drugs directly to consumers and public-awareness campaigns about depression. Read more...

Ayurtox for Body Detoxification

Source:
http://feeds.feedburner.com/integratedmedicine

The Ellis Martin Report: Interview with International Stem Cell Corporation's Founder and Co-Chairman Kenneth Aldrich Lifeline Skin Care -- LLSC Remodeled marketing and structure of subsidiary to reach broader base of users and use multiple distribution channels including International distribution network, spas and resorts plus increased product supply.

Read more here:
Ellis Martin Report with International Stem Cell Corp - YouTube2.flv - Video

"I thought there was absolutely no hope and that I was destined to pass away." Ron was diagnosed with COPD in 200.

Read the original here:
Before/After Stem Cell for COPD: From Unable to Walk, to Dancing at My Daughter's Wedding - Video